These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8290178)

  • 1. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants.
    Holland EF; Studd JW; Mansell JP; Leather AT; Bailey AJ
    Obstet Gynecol; 1994 Feb; 83(2):180-3. PubMed ID: 8290178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphometric changes in the skeleton of postmenopausal women with low bone mineral density treated with percutaneous estradiol implants.
    Holland EF; Chow JW; Studd JW; Leather AT; Chambers TJ
    Obstet Gynecol; 1994 Mar; 83(3):387-91. PubMed ID: 8127530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 25-mg percutaneous estradiol implants on the bone mass of postmenopausal women.
    Holland EF; Leather AT; Studd JW
    Obstet Gynecol; 1994 Jan; 83(1):43-6. PubMed ID: 8272305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis.
    Khastgir G; Studd J; Holland N; Alaghband-Zadeh J; Sims TJ; Bailey AJ
    Osteoporos Int; 2001; 12(6):465-70. PubMed ID: 11446562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
    Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis.
    Gonnelli S; Cepollaro C; Pondrelli C; Martini S; Monaco R; Gennari C
    J Bone Miner Res; 1997 Apr; 12(4):624-31. PubMed ID: 9101374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year follow-up of the use of transdermal 17beta-estradiol matrix patches for the prevention of bone loss in early postmenopausal women.
    Delmas PD; Pornel B; Felsenberg D; Stakkestad JA; Radowicki S; Garnero P; Hardy P; Dain MP; Petitier B;
    Am J Obstet Gynecol; 2001 Jan; 184(2):32-40. PubMed ID: 11174476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Observation of preventing of bone loss during early postmenopause by percutaneous estradiol in Chinese postmenopausal women].
    Sun A; Lin S; Wei Y
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jun; 36(6):348-51. PubMed ID: 11783133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
    Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route.
    Delmas PD; Marianowski L; Perez Ade C; Ribot C; Pornel B; Palacios S; Lopes P;
    Maturitas; 2004 Jun; 48(2):85-96. PubMed ID: 15172082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.
    García-Pérez MA; Moreno-Mercer J; Tarín JJ; Cano A
    Gynecol Endocrinol; 2006 Apr; 22(4):179-84. PubMed ID: 16723303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone implants.
    Garnett T; Studd J; Watson N; Savvas M; Leather A
    Obstet Gynecol; 1992 Jun; 79(6):968-72. PubMed ID: 1579324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women.
    Bagur A; Wittich A; Ghiringhelli G; Vega E; Mautalen C
    Medicina (B Aires); 1996; 56(3):247-51. PubMed ID: 9035480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
    Warming L; Ravn P; Christiansen C
    Maturitas; 2005 Feb; 50(2):78-85. PubMed ID: 15653003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.